Biol Reprod
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pearce-Pratt, R.
Right arrow Articles by Phillips, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pearce-Pratt, R.
Right arrow Articles by Phillips, D. M.
Agricola
Right arrow Articles by Pearce-Pratt, R.
Right arrow Articles by Phillips, D. M.

Biology of Reproduction, Vol 54, 173-182, Copyright © 1996 by Society for the Study of Reproduction


ARTICLES

Sulfated polysaccharides inhibit lymphocyte-to-epithelial transmission of human immunodeficiency virus-1

R Pearce-Pratt and DM Phillips
Population Council, New York, New York 10021, USA.

We have previously suggested that sulfated polysaccharides could be used in a vaginal formulation to inhibit infection by human immunodeficiency virus (HIV-1). This supposition was based on studies in which we developed and employed an in vitro model to simulate the mechanism of HIV-1 transmission during coitus. We found that adhesion of mononuclear cells to epithelia was the initial step in infection and speculated that blocking adhesion would prevent HIV-1 transmission. We observed that certain sulfated polysaccharides prevented adhesion of lymphoma cell lines to epithelial cell lines, which were derived from the genital tract, in concentrations of a few milligrams per milliliter; and we theorized that sulfated polysaccharides could thus be used as active ingredients in a topical "microbicide." In the present in vitro study, evidence is presented that a number of sulfated polysaccharides, including carrageenan, dextran sulfate, heparin, fucoidan, and pentosan polysulfate, are capable of blocking infection by mechanisms other than adhesion at concentrations of a thousand times lower than the dosages that are needed to block cell adhesion. One of these compounds, iota carrageenan, is capable not only of blocking infection of epithelia at concentrations of 1-2 micrograms, but of blocking adhesion to a far greater extent than the other sulfated polysaccharides tested. For this reason, as well as for considerations of safety, stability, and gelling properties, we suggest that iota carrageenan may be the best choice of the sulfated polysaccharides tested for use as a vaginal microbicide. The same in vitro model was employed to decipher the cell surface molecules involved in lymphocyte- to-epithelial adhesion. To accomplish this, we screened for the presence of cell adhesion molecules (CAMs), carbohydrates, proteoglycans, and carbohydrate-binding sites. HIV-1-infected lymphocytic cells expressed a CAM profile typical of activated, infected cells (e.g., HLA-DR+, CD4-, LFA-1+, ICAM-1+, LFA-3+, CD2+) whereas epithelia expressed few CAMs (LFA-3, ICAM-1, VLA-5, CD44, CD26, sLEX). Both cell types expressed heparan sulfate and chondroitin sulfate proteoglycans. A variety of sugars (mannose, fucose, galactose, Nac-galactosamine, Nac-glucosamine) were also present, but these cells expressed few carbohydrate-binding sites; lymphocytes bound beta- galactose. We were unable to block the adhesion with anti-CAM antibodies or with exogenous sugars. When enzymes were used against sulfated cell surface molecules, chondroitinase was found to block the adhesion. Our evidence suggests that this CAM-independent adhesion may be a lectin-glycosaminoglycan interaction.


This article has been cited by other articles:


Home page
J. Virol.Home page
R. P. Madan, P. M. M. Mesquita, N. Cheshenko, B. Jing, V. Shende, E. Guzman, T. Heald, M. J. Keller, S. L. Regen, R. J. Shattock, et al.
Molecular Umbrellas: a Novel Class of Candidate Topical Microbicides To Prevent Human Immunodeficiency Virus and Herpes Simplex Virus Infections
J. Virol., July 15, 2007; 81(14): 7636 - 7646.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. J. Chancey, K. V. Khanna, J. F. M. L. Seegers, G. W. Zhang, J. Hildreth, A. Langan, and R. B. Markham
Lactobacilli-Expressed Single-Chain Variable Fragment (scFv) Specific for Intercellular Adhesion Molecule 1 (ICAM-1) Blocks Cell-Associated HIV-1 Transmission across a Cervical Epithelial Monolayer
J. Immunol., May 1, 2006; 176(9): 5627 - 5636.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
G. F. Doncel
Exploiting common targets in human fertilization and HIV infection: development of novel contraceptive microbicides
Hum. Reprod. Update, March 1, 2006; 12(2): 103 - 117.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
F. Liners, W. Helbert, and P. Van Cutsem
Production and characterization of a phage-display recombinant antibody against carrageenans: evidence for the recognition of a secondary structure of carrageenan chains present in red algae tissues
Glycobiology, September 1, 2005; 15(9): 849 - 860.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
G. N. Milligan, C.-F. Chu, C. G. Young, and L. R. Stanberry
Effect of Candidate Vaginally-Applied Microbicide Compounds on Recognition of Antigen by CD4+ and CD8+ T Lymphocytes
Biol Reprod, November 1, 2004; 71(5): 1638 - 1645.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
N. Cheshenko, M. J. Keller, V. MasCasullo, G. A. Jarvis, H. Cheng, M. John, J.-H. Li, K. Hogarty, R. A. Anderson, D. P. Waller, et al.
Candidate Topical Microbicides Bind Herpes Simplex Virus Glycoprotein B and Prevent Viral Entry and Cell-to-Cell Spread
Antimicrob. Agents Chemother., June 1, 2004; 48(6): 2025 - 2036.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
M. J. Keller, M. E. Klotman, and B. C. Herold
Rigorous pre-clinical evaluation of topical microbicides to prevent transmission of human immunodeficiency virus
J. Antimicrob. Chemother., May 1, 2003; 51(5): 1099 - 1102.
[Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S. Sinha, N. Cheshenko, R. I. Lehrer, and B. C. Herold
NP-1, a Rabbit {alpha}-Defensin, Prevents the Entry and Intercellular Spread of Herpes Simplex Virus Type 2
Antimicrob. Agents Chemother., February 1, 2003; 47(2): 494 - 500.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
T. L. Tollner, J. W. Overstreet, M. W. Li, S. A. Meyers, A. I. Yudin, E. R. Salinas, and G. N. Cherr
Lignosulfonic Acid Blocks In Vitro Fertilization of Macaque Oocytes When Sperm Are Treated Either Before or After Capacitation
J Androl, November 1, 2002; 23(6): 889 - 898.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Zen, Y. Liu, D. Cairo, and C. A. Parkos
CD11b/CD18-Dependent Interactions of Neutrophils with Intestinal Epithelium Are Mediated by Fucosylated Proteoglycans
J. Immunol., November 1, 2002; 169(9): 5270 - 5278.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B. C. Herold, I. Scordi-Bello, N. Cheshenko, D. Marcellino, M. Dzuzelewski, F. Francois, R. Morin, V. M. Casullo, R. A. Anderson, C. Chany II, et al.
Mandelic Acid Condensation Polymer: Novel Candidate Microbicide for Prevention of Human Immunodeficiency Virus and Herpes Simplex Virus Entry
J. Virol., October 17, 2002; 76(22): 11236 - 11244.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
R. A. Anderson, K. A. Feathergill, X.-H. Diao, M. D. Cooper, R. Kirkpatrick, B. C. Herold, G. F. Doncel, C. J. Chany, D. P. Waller, W. F. Rencher, et al.
Preclinical Evaluation of Sodium Cellulose Sulfate (Ushercell) as a Contraceptive Antimicrobial Agent
J Androl, May 1, 2002; 23(3): 426 - 438.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
L. J.D. Zaneveld, D. P. Waller, R. A. Anderson, C. Chany II, W. F. Rencher, K. Feathergill, X.-H. Diao, G. F. Doncel, B. Herold, and M. Cooper
Efficacy and Safety of a New Vaginal Contraceptive Antimicrobial Formulation Containing High Molecular Weight Poly(Sodium 4-Styrenesulfonate)
Biol Reprod, April 1, 2002; 66(4): 886 - 894.
[Abstract] [Full Text] [PDF]


Home page
Sex. Transm. Infect.Home page
C Coggins, K Blanchard, F Alvarez, V Brache, E Weisberg, P H Kilmarx, M Lacarra, R Massai, D Mishell Jr, A Salvatierra, et al.
Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide
Sex. Transm. Inf., December 1, 2000; 76(6): 480 - 483.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
O. J. D'Cruz, M.-J. Shih, S. H. Yiv, C.-L. Chen, and F. M. Uckun
Synthesis, characterization and preclinical formulation of a dual-action phenyl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07) with potent anti-HIV and spermicidal activities
Mol. Hum. Reprod., May 1, 1999; 5(5): 421 - 432.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Rusnati, C. Urbinati, A. Caputo, L. Possati, H. Lortat-Jacob, M. Giacca, D. Ribatti, and M. Presta
Pentosan Polysulfate as an Inhibitor of Extracellular HIV-1 Tat
J. Biol. Chem., June 15, 2001; 276(25): 22420 - 22425.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the Society for the Study of Reproduction.